ROCHE FORTIFYING RECOMBINANT INTERLEUKIN-2 PATENT POSITION THROUGH AGREEMENT WITH AJINOMOTO; JAPANESE FIRM WAS FIRST TO CLONE PROTEIN

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".